ArticleBlood2017

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.

Michelle M McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.